11:14 AM EDT, 05/15/2024 (MT Newswires) -- Yield10 Bioscience ( YTEN ) said Wednesday it received a final delisting notice from Nasdaq after failing to regain compliance with the exchange's listing rule that requires listed firms to maintain stockholder's equity of at least $2.5 million.

The company said trading of its shares on the exchange will be suspended at market open Thursday.

Yield10 said its shares will trade on the over-the-counter market, and it plans to apply for trading on the OTC-QB market.

The company shares were down about 43% in recent trading.

Price: 2.98, Change: -2.28, Percent Change: -43.35